Mycophenolate Mofetil-Related Celiac-Like Enteropathy With Devastating Superior Mesenteric Artery Thrombosis and...

Area of Science:

• Immunology
• Nephrology
• Neurology

Background:

• Mycophenolate mofetil (MMF) is a key immunosuppressant in organ transplantation, primarily for preventing acute rejection.
• It is generally perceived to have a favorable safety profile, with gastrointestinal disturbances being the most common adverse effects.

Observation:

• A case study involving a renal transplant recipient on long-term MMF therapy.
• The patient developed de novo celiac-like enteropathy, epilepsy, and cerebral occipital calcifications.

Findings:

• These symptoms collectively resemble Gobbi syndrome, a rare condition.
• This presentation suggests a potential association between prolonged MMF use and severe neurological and gastrointestinal complications.

Implications:

• Highlights the importance of vigilant monitoring for both gastrointestinal and neurological symptoms in patients receiving MMF.
• Underscores the need for further research into the mechanisms of MMF-induced celiac-like disease and associated neurological conditions.
• Suggests the development of evidence-based guidelines for managing these rare but severe adverse effects.